Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dopable Bioink for Augmented Tissue Engineering in Craniofacial Reconstruction, Innovative Pipeline for Drug Design and Selective Delivery Through Functionalized Polymeric Nanoparticles.

NCT06533150 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.

NCT NCT06533150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06533150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dopable Bioink for Augmented Tissue Engineering in Craniofacial Reconstruction, Innovative Pipeline for Drug Design and Selective Delivery Through Functionalized Polymeric Nanoparticles.
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Observational
Overall status
Active, not recruiting
Start date
October 7, 2024
Completion date
October 1, 2026
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

craniofacial defects, subtle, craniosynostoses, skull defect